Evidence map›Paper›PMID 37738163›Full record

ArticleBlood advances2023

Age-specific impact of type I interferons on cerebral thrombosis and inflammation.

Frederik Denorme, Izabella Andrianova, Mark J Cody, Yasuhiro Kosaka, Robert A Campbell

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Platelet mTOR Is a Regulator of Sterile Immunothrombosis.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Article
  3. Article
  4. Immunothrombosis in neurovascular disease.Research and practice in thrombosis and haemostasis · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Frederik DenormeUniversity of Utah Molecular Medicine Program, Salt Lake City, UT.
Izabella AndrianovaUniversity of Utah Molecular Medicine Program, Salt Lake City, UT.
Mark J CodyUniversity of Utah Molecular Medicine Program, Salt Lake City, UT.
Yasuhiro KosakaUniversity of Utah Molecular Medicine Program, Salt Lake City, UT.
Robert A CampbellUniversity of Utah Molecular Medicine Program, Salt Lake City, UT.
University of Utah · US

Funding

Platelet-Mediated Neutrophil Extracellular Traps Regulate Ischemic Stroke InjuryR01HL163019 · NHLBI · WASHINGTON UNIVERSITY · PI CAMPBELL, ROBERT A · 2022 to 2025
$2.2M
HUMAN PLATELET PAR4: NOVEL ACTIVATION, INTERINDIVIDUAL VARIATION, AND NEUTROPHIL INTERACTIONS IN VIVO AND IN VITROR01HL160808 · NHLBI · WASHINGTON UNIVERSITY · PI CAMPBELL, ROBERT A · 2022 to 2025
$2.1M
Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in AgingK01AG059892 · NIA · UNIVERSITY OF UTAH · PI CAMPBELL, ROBERT A · 2019 to 2022
$400k
NHLBI NIH HHS R01 HL160808NHLBI NIH HHS R01 HL163019NIA NIH HHS K01 AG059892
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interferon Type IIntracranial ThrombosisAge FactorsHumansInflammationInterferon Type I

Identifiers

PMID37738163
PMCPMC10637883
OpenAlexW4386954836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.